Persisting antibodies to glutamic acid decarboxylase in Type 1 (insulin-dependent) diabetes mellitus are not associated with neuropathy
DiabetologiaPublished 1 July 1993Open access
Jaakko Tuomilehto
Citations16
SJR quartileQ1
SJR score3.62
SNIP2.67
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
It is found that the decrease in frequency of positivity for anti-GAD in Type 1 diabetic patients is not nearly as great as for ICA b, and the frequency found for all Type i diabetic patients of more than 10 years duration irrespective of the presence or not of clinically evident neuropathy.
Abstract
Persisting antibodies to glutamic acid decarboxylase in Type 1 (insulin-dependent) diabetes mellitus are not associated with neuropathy
Keywords
MedicineBiochemistry, Genetics and Molecular Biology
NatureIdentification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase
1,966 Citations1990Steinunn Bækkeskov, Henk‐Jan Aanstoot +7 more
The pancreatic islet β-cell autoantigen of relative molecular mass 64,000 (64K), which is a major target of autoantibodies associated with the development of insulin-dependent diabetes mel-litus (IDDM), has been identified as glutamic acid decarboxylase, the biosynthesizing enzyme of the inhibitory neurotransmitter GABA.
Journal of Clinical InvestigationAutoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus.
490 Citations1992D L Kaufman, Mark G. Erlander +4 more
A striking sequence similarity between the two GADs and Coxsackievirus, a virus that has been associated with IDDM both in humans and in experimental animals, suggests that molecular mimicry may play a role in the pathogenesis of IDDM.
NatureErratum: Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase
352 Citations1990Steinunn Bækkeskov, Henk‐Jan Aanstoot +7 more
In the published version of this article, the name of one of the authors (P. De C.) was incorrectly hyphenated.
Journal of Clinical InvestigationAntibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes.
318 Citations1987Steinunn Bækkeskov, Maria A. Landin +8 more
Results suggest that antibodies against the Mr 64,000 human islet protein are an early marker of beta-cell autoimmunity and may be useful to predict a later development of IDDM.
DiabetesAntibodies to Glutamic Acid Decarboxylase Discriminate Major Types of Diabetes Mellitus
154 Citations1992Merrill J. Rowley, Ian R Mackay +3 more
A simple laboratory test with a defined autoantigen has substantial implications for population screening and early diagnosis of IDDM and for better understanding of its pathogenesis.
Current Opinion in ImmunologyAutoimmunity associated with infection: leprosy, acute rheumatic fever and Lyme disease
23 Citations1991Michael R. Ehrenstein, David Isenberg